-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
South African regulators announced on the 13th that South Africa will not distribute millions of doses of "problem vaccines" produced in a US factory, and is discussing exchanges with vaccine supplier Johnson & Johnson
The South African Health Products Regulatory Authority issued a statement saying that after evaluating the data provided by the US Food and Drug Administration, the agency decided not to distribute the new crown vaccine delivered by Johnson & Johnson that may have raw material contamination problems
Officials from the South African Ministry of Health said the decision involved 2 million doses of Johnson & Johnson vaccines, which are currently stored in a laboratory of South Africa’s largest pharmaceutical company, Ai Shijian
The official said that the South African government is negotiating with Johnson & Johnson to return the vaccine